Undiscovered Gems in Asia to Explore This July 2026
As geopolitical tensions in the Middle East and fluctuating oil prices dominate global headlines, Asian markets are navigating a complex landscape with mixed performances across key indices. Amidst these dynamics, investors are increasingly on the lookout for small-cap opportunities that demonstrate resilience and growth potential in sectors less impacted by such volatility. Identifying stocks with strong fundamentals, innovative capabilities, and strategic positioning can be crucial for those seeking to uncover hidden gems within this diverse region.
Top 10 Undiscovered Gems With Strong Fundamentals In Asia
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| CNMC Goldmine Holdings | 0.84% | 32.52% | 78.36% | ★★★★★★ |
| Transcend Information | NA | 4.45% | 25.56% | ★★★★★★ |
| DeHua TB New Decoration MaterialLtd | 0.63% | 1.50% | 2.14% | ★★★★★★ |
| Hyundai Home Shopping Network | 6.43% | 16.06% | -2.84% | ★★★★★★ |
| Base | NA | 11.66% | 17.63% | ★★★★★★ |
| Zhejiang Jolly PharmaceuticalLTD | 21.31% | 17.83% | 29.70% | ★★★★★☆ |
| Magnate Technology | 77.36% | 10.92% | 35.95% | ★★★★★☆ |
| Sing Investments & Finance | 0.15% | 7.06% | 8.65% | ★★★★☆☆ |
| Shengda ResourcesLtd | 54.08% | 7.99% | 3.75% | ★★★☆☆☆ |
| Regina Miracle International (Holdings) | 132.81% | 0.48% | -15.87% | ★★★☆☆☆ |
We're going to check out a few of the best picks from our screener tool.
SWS Hemodialysis Care (SHSE:688410)
Simply Wall St Value Rating: ★★★★★★
Overview: SWS Hemodialysis Care Co., Ltd. offers integrated blood purification solutions for renal failure and critically ill patients on an international scale, with a market capitalization of CN¥4.58 billion.
Operations: SWS Hemodialysis Care generates revenue primarily from its integrated blood purification solutions. The company’s financial performance is highlighted by a net profit margin of 15%.
SWS Hemodialysis Care is capturing attention with its impressive performance and innovative offerings. The company reported a sales increase to CNY 229.63 million in Q1 2026, up from CNY 189.26 million the previous year, alongside net income rising to CNY 54.48 million from CNY 37.01 million. Notably debt-free, SWS's earnings grew by an astonishing 121% over the past year, outpacing the industry average of -10%. With its stock trading at a significant discount of nearly 73% below estimated fair value and plans for a stock split on July 10, SWS stands out as a compelling prospect in Asia's medical equipment sector.
- Click to explore a detailed breakdown of our findings in SWS Hemodialysis Care's health report.
Understand SWS Hemodialysis Care's track record by examining our Past report.
DeHua TB New Decoration MaterialLtd (SZSE:002043)
Simply Wall St Value Rating: ★★★★★★
Overview: DeHua TB New Decoration Material Co., Ltd specializes in the production and sale of environmentally friendly furniture panels both within China and internationally, with a market cap of CN¥9.02 billion.
Operations: The company's revenue is primarily derived from the production and sale of environmentally friendly furniture panels. It has a market cap of CN¥9.02 billion, reflecting its valuation in the market.
DeHua TB New Decoration Material Co., Ltd. has shown notable financial resilience, with earnings growth of 25% over the past year, surpassing the Forestry industry's -3%. The company reports a net income of CNY 148 million for Q1 2026, up from CNY 101 million the previous year. Its debt-to-equity ratio impressively reduced from 54.9% to just 0.6% over five years, indicating strong financial management. Despite a large one-off gain of CN¥244.8M impacting recent results, it trades at an attractive value—53% below estimated fair value—and forecasts suggest earnings will grow by roughly 13% annually moving forward.
Rayhoo Motor DiesLtd (SZSE:002997)
Simply Wall St Value Rating: ★★★★★☆
Overview: Rayhoo Motor Dies Co., Ltd. operates in the automobile manufacturing equipment and lightweight parts sectors both in China and internationally, with a market cap of CN¥6.04 billion.
Operations: Rayhoo Motor Dies Co., Ltd. generates revenue primarily from its automobile manufacturing equipment and lightweight parts sectors, serving both domestic and international markets. The company has a market cap of CN¥6.04 billion.
Rayhoo Motor Dies Ltd., a smaller player in the machinery sector, shows promising potential with its earnings growing 7.9% over the past year, outpacing the industry average of 1.9%. The company reported first-quarter sales of CNY 1.01 billion, up from CNY 747.12 million last year, while net income rose to CNY 106.75 million from CNY 97.44 million previously. Trading at about half its estimated fair value suggests an attractive entry point for investors seeking undervalued opportunities in Asia's market landscape. With more cash than total debt and strong interest coverage, Rayhoo appears financially sound for future growth prospects.
- Get an in-depth perspective on Rayhoo Motor DiesLtd's performance by reading our health report here.
Make It Happen
- Click here to access our complete index of 106 Asian Undiscovered Gems With Strong Fundamentals.
- Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Looking For Alternative Opportunities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com